HR 124 119th Congress House In Committee

Byron Nash Renal Medullary Carcinoma Awareness Act of 2023

Latest action: Referred to the House Committee on Energy and Commerce. · Jan 3, 2025

View full text on Congress.gov ↗ Policy area: Health

Legislative Summary

Byron Nash Renal Medullary Carcinoma Awareness Act of 2023 [ sic ] This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)

Source: Congressional Research Service (CRS).

Sponsor

Rep. Green, Al [D-TX-9]
Independent · TX

Track HR 124 in BallotBox360

Get real-time bill updates, floor vote alerts, and AI-powered summaries — all in one app.

Download on iOS Open Web App